
NASDAQHealthcareMedical - Equipment & Services
最新数据
US$18.40
−US$0.40 · -2.13%
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
前收盘价
US$18.40
−US$0.40 · -2.13%
盘后
US$18.50
+US$0.10 · +0.54%
10月13日 19:53 ET
盘中时间采用ET。市场数据可能有所延迟。
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
日内区间
当前US$18.40
52周区间
当前US$18.40
盘中时间采用ET。市场数据可能有所延迟。
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.
日内区间
当前US$18.40
52周区间
当前US$18.40
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 |
|---|---|---|---|---|
| 营收 | 31.02亿 USD | 27.15亿 USD | 24.69亿 USD | 22.45亿 USD |
| 销货成本 | 14.22亿 USD | 11.9亿 USD | 10.32亿 USD | 9.37亿 USD |
| 毛利 | 16.8亿 USD | 15.25亿 USD | 14.36亿 USD | 13.08亿 USD |
| 研究与开发 | 4.48亿 USD | 4.38亿 USD | 4.37亿 USD | 4.29亿 USD |
| 销售、一般及管理费用 | 11.83亿 USD | 11.31亿 USD | 10.57亿 USD | 9.6亿 USD |
| 营业费用 | 16.31亿 USD | 17.27亿 USD | 15.06亿 USD | 13.77亿 USD |
| 折旧和摊销 | 1.56亿 USD | 1.43亿 USD | 1.29亿 USD | 1.15亿 USD |
| 营业利润 | 4900万 USD | −2.02亿 USD | −6900万 USD | −6900万 USD |
| 净利润 | −3.31亿 USD | −2.5亿 USD | −1.12亿 USD | −9600万 USD |
公司数据更新于 2026年10月14日。
近期已公布业绩
近期已公布业绩
报告持有此股票敞口的交易所交易基金。
First Trust US Equity Opportunities ETFFPX1510.6万1.05%14.46亿 USD0.57%US$177.36-0.60%
iShares Russell 2000 ETFIWM1395.41万0.02%777.48亿 USD0.19%US$276.7-0.43%
Vanguard Extended Market ETFVXF663.55万0.01%954亿 USD0.05%US$232.54-0.42%
iShares Russell 2000 Value ETFIWN501.61万0.04%137.52亿 USD0.24%US$210.99-0.05%
Vanguard Russell 2000 ETFVTWO335.05万0.02%180亿 USD0.06%US$111.77-0.45%
Ballast Small/Mid Cap ETFMGMT307.56万1.87%1.64亿 USD1.17%US$49.12+0.10%
Schwab U.S. Small-Cap ETFSCHA275.55万0.01%217.13亿 USD0.03%US$32.56-0.31%
State Street SPDR S&P Health Care Equipment ETFXHE186.24万1.07%1.68亿 USD0.35%US$90.21-0.73%
First Trust US Equity Opportunities ETFFPX
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
iShares Russell 2000 Value ETFIWN
Vanguard Russell 2000 ETFVTWO
Ballast Small/Mid Cap ETFMGMT
Schwab U.S. Small-Cap ETFSCHA
State Street SPDR S&P Health Care Equipment ETFXHEAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。